Clinical Trials Logo

Smoking Reduction clinical trials

View clinical trials related to Smoking Reduction.

Filter by:

NCT ID: NCT03083353 Completed - Smoking Cessation Clinical Trials

Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation

Start date: January 22, 2020
Phase: Early Phase 1
Study type: Interventional

The proposed study represents a crucial and important stage in translating basic research to strategies for treating nicotine dependence. The investigation addresses an important public health issue by testing an intervention - informed by basic research - that may lead to a more effective and efficient treatment for smokers. The expected findings should provide initial effect size data for the addition of isradipine to an integrated psychosocial/behavioral and pharmacological smoking cessation intervention for smokers, and thus provide the necessary data for a large-scale follow-up trial.